Bristol-Myers Squibb Company logo
Bristol-Myers Squibb Company BMY
$ 59.46 -0.15%

Annual report 2025
added 02-11-2026

report update icon

Bristol-Myers Squibb Company DSO Ratio 2011-2026 | BMY

Annual DSO Ratio Bristol-Myers Squibb Company

2025 2024 2023 2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
83.9 81.9 84.4 76.1 70.3 69.5 107 96.5 111 104 94.8 77.9 74.8 63.9 64.3

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
111 63.9 84

Quarterly DSO Ratio Bristol-Myers Squibb Company

2025-Q2 2025-Q1 2024-Q3 2024-Q2 2024-Q1 2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
82.6 88.9 86.1 81.8 79.8 84.9 82 80.2 - 39.1 32.7 70 - 71.7 68.9 70.7 70.1 73.6 76.6 68.5 88.3 117 112 104 89.5 95.6 95.4 108 106 109 112 110 96.5 103 104 102 91.5 96.4 94.2 86.8 72.7 78.9 79.5 80.8 69 75.4 75.7 76.7 67.1 75.3 63.3 59.3 62.6 63.9 62.9 -

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
117 32.7 82.8

DSO Ratio of other stocks in the Biotechnology industry

Issuer DSO Ratio Price % 24h Market Cap Country
FSD Pharma FSD Pharma
HUGE
2.94 K - 5743.5 % $ 69.7 M canadaCanada
Happiness Biotech Group Limited Happiness Biotech Group Limited
HAPP
29 - 1.35 % $ 17.8 M chinaChina
AgeX Therapeutics AgeX Therapeutics
AGE
186 - -10.17 % $ 12.2 K usaUSA
I-Mab I-Mab
IMAB
271 - - $ 866 M chinaChina
Alexion Pharmaceuticals, Inc. Alexion Pharmaceuticals, Inc.
ALXN
84.7 - - $ 40.3 B usaUSA
EyeGate Pharmaceuticals, Inc. EyeGate Pharmaceuticals, Inc.
EYEG
2.75 K - -1.52 % $ 24.7 M usaUSA
Midatech Pharma plc Midatech Pharma plc
MTP
204 - -18.52 % $ 27.3 M britainBritain
Esperion Therapeutics Esperion Therapeutics
ESPR
99.7 $ 3.13 - $ 651 M usaUSA
Eton Pharmaceuticals Eton Pharmaceuticals
ETON
39.1 $ 32.59 -6.89 % $ 877 M usaUSA
Affimed N.V. Affimed N.V.
AFMD
31.4 - -34.95 % $ 21.5 M germanyGermany
Celyad Oncology SA Celyad Oncology SA
CYAD
64.4 - - $ 12.5 M belgiumBelgium
Berkeley Lights Berkeley Lights
BLI
103 - -7.31 % $ 87 M usaUSA
Generation Bio Co. Generation Bio Co.
GBIO
47.6 - - $ 344 M usaUSA
IMV IMV
IMV
2.16 K - - $ 13.1 M canadaCanada
Autolus Therapeutics plc Autolus Therapeutics plc
AUTL
58.2 $ 1.7 3.03 % $ 452 M britainBritain
Ayala Pharmaceuticals Ayala Pharmaceuticals
AYLA
61.7 - - $ 7.46 M israelIsrael
Heron Therapeutics Heron Therapeutics
HRTX
198 $ 0.86 -1.42 % $ 143 M usaUSA
Cyclacel Pharmaceuticals Cyclacel Pharmaceuticals
CYCCP
3.66 K - -4.36 % $ 27 M usaUSA
Compugen Ltd. Compugen Ltd.
CGEN
400 $ 2.8 7.28 % $ 262 M israelIsrael
Anika Therapeutics Anika Therapeutics
ANIK
76.5 $ 14.88 -0.93 % $ 213 M usaUSA
Advaxis Advaxis
ADXS
3.28 K - -9.65 % $ 45.9 M usaUSA
Incyte Corporation Incyte Corporation
INCY
66.6 $ 97.16 -0.26 % $ 19 B usaUSA
Ionis Pharmaceuticals Ionis Pharmaceuticals
IONS
20.5 $ 75.56 -0.29 % $ 12.1 B usaUSA
Aeterna Zentaris Aeterna Zentaris
AEZS
146 - 5.93 % $ 314 M canadaCanada
Aeglea BioTherapeutics Aeglea BioTherapeutics
AGLE
216 - - $ 1.01 B usaUSA
CureVac N.V. CureVac N.V.
CVAC
13.6 - - $ 867 M germanyGermany
Applied Genetic Technologies Corporation Applied Genetic Technologies Corporation
AGTC
126 - - $ 26.5 M usaUSA
Can-Fite BioPharma Ltd. Can-Fite BioPharma Ltd.
CANF
28.1 $ 3.4 -1.16 % $ 5.6 M israelIsrael
AIkido Pharma AIkido Pharma
AIKI
17.9 - 1.93 % $ 17.4 M usaUSA
Aptinyx Aptinyx
APTX
46.9 - -39.0 % $ 4.57 M usaUSA
Coherus BioSciences Coherus BioSciences
CHRS
559 $ 1.61 2.55 % $ 189 M usaUSA
Albireo Pharma Albireo Pharma
ALBO
14.7 - -0.23 % $ 916 M usaUSA